Jo Klaveness

[vc_empty_space height=”80px”][vc_row][vc_column][vc_row_inner css=”.vc_custom_1476862185021{padding-bottom: 30px !important;}”][vc_column_inner width=”2/3″][vc_column_text css=”.vc_custom_1477985450741{margin-bottom: 20px !important;}”]

Jo Klaveness

Scientific Advisory Board
[/vc_column_text][labora_vc_staff_info][/vc_column_inner][/vc_row_inner] [vc_row_inner css=”.vc_custom_1476862170589{padding-bottom: 30px !important;}”][vc_column_inner][vc_column_text]

Area of Expertise

Jo Klaveness is a professor of medical chemistry at the University of Oslo’s School of Pharmacy and the founder of Drug Discovery Laboratory AS. He has a doctoral degree and a master’s degree in organic chemistry as well as an MSc Pharm. in pharmaceutical chemistry from the University of Oslo. He has held several positions in Nycomed, including as project manager and head of the R&D organisation, and served in several boards of directors, including for Pronova Biopharma ASA and Omegatri AS. Klaveness is the inventor of more than 160 patent families related to several pharmaceutical products that are on the market. 

[/vc_column_text][/vc_column_inner][/vc_row_inner][/vc_column][/vc_row]